Rochester Democrat & Chronicle names iCardiac Technologies a Winner of the 2016 Rochester Metro Area Top Workplaces Award

March 29, 2016, Rochester, N.Y. – iCardiac Technologies, Inc. has been awarded a 2016 Top Workplaces honor by the Rochester Democrat & Chronicle for the second time.

The 2016 award comes on the heels of a period of exceptionally quick growth for iCardiac, including through an acquisition of a new division in July 2015.

“At iCardiac, our team makes a critical contribution to the healthcare industry by helping pharmaceutical researchers to more effectively assess the safety and efficacy of new medications,” said Alex Zapesochny, president and CEO of iCardiac. “Though working at a fast-growing company in a demanding industry comes with frequent challenges, through a focus on creating a workplace driven by respect, kindness and trust, our team consistently does an outstanding job supporting one another and serving our customers. Being recognized as a Top Workplace is a testament to those team-oriented values.”

The Top Workplaces lists are based solely on the results of an employee feedback survey administered by WorkplaceDynamics, LLC, a leading research firm that specializes in organizational health and workplace improvement. Several aspects of workplace culture were measured, including alignment, execution, and connection, just to name a few.

“The Top Workplaces award is not a popularity contest. And oftentimes, people assume it’s all about fancy perks and benefits.” says Doug Claffey, CEO of WorkplaceDynamics. “But to be a Top Workplace, organizations must meet our strict standards for organizational health. And who better to ask about work life than the people who live the culture every day—the employees.”

About iCardiac Technologies

iCardiac Technologies, Inc. is an industry-leading centralized core laboratory for respiratory and cardiac safety services.  Its high precision cardiac safety assessment methodology has set a new standard for precision and accuracy in all phases of clinical trials.  The company serves 8 of the top 10 global pharmaceutical companies, as well as numerous small and mid-sized pharma and biotechnology firms.  For more information, please visit: